Complete response to romidepsin as monotherapy in treatment-resistant subcutaneous panniculitis-like T-cell lymphoma

Balaji Jothishankar; Maria L Espinosa; Jasmine Zain; Vishwas Parekh; Cosimo Di Raimondo; Farah Abdulla

doi:10.1016/j.jdcr.2020.09.018

Complete response to romidepsin as monotherapy in treatment-resistant subcutaneous panniculitis-like T-cell lymphoma

JAAD Case Rep. 2020 Oct 7;6(12):1245-1247. doi: 10.1016/j.jdcr.2020.09.018. eCollection 2020 Dec.

Authors

Balaji Jothishankar¹, Maria L Espinosa¹, Jasmine Zain², Vishwas Parekh², Cosimo Di Raimondo², Farah Abdulla²

Affiliations

¹ University of Chicago Pritzker School of Medicine, Chicago, Illinois.
² City of Hope Los Angeles, Duarte, California.

No abstract available

Keywords: CHOP, cyclophosphamide, doxorubicin, vincristine, and prednisone; HPS, hemophagocytic syndrome; SPTCL; SPTCL, subcutaneous panniculitis-like T-cell lymphoma; romidepsin; subcutaneous panniculitis-like T-cell lymphoma; therapeutic.

Publication types

Case Reports